DEA schedule
Is abiraterone acetate a controlled substance?
Federal schedule for abiraterone acetate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Abiraterone acetate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abiraterone acetate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted abiraterone acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 43 prescription listings from 26 labelers, none with a DEA schedule |
| DEA controlled substances list | abiraterone acetate is not on the list |
Abiraterone Acetate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 51407-503 | ABIRATERONE ACETATE | tablet | 125 mg/1 | Golden State Medical Supply, Inc. | None |
| 47335-401 | YONSA | tablet | 125 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 57894-150 | Zytiga | tablet | 250 mg/1 | Janssen Biotech, Inc. | None |
| 57894-195 | Zytiga | tablet, film coated | 500 mg/1 | Janssen Biotech, Inc. | None |
| 0143-9597 | Abiraterone | tablet | 250 mg/1 | Hikma Pharmaceuticals USA Inc. | None |
| 68001-489 | Abiraterone | tablet | 250 mg/1 | BluePoint Laboratories | None |
| 72205-030 | Abiraterone | tablet | 250 mg/1 | Novadoz Pharmaceuticals LLC | None |
| 72789-213 | Abiraterone | tablet | 250 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 82009-139 | Abiraterone | tablet | 250 mg/1 | Quallent Pharmaceuticals Health LLC | None |
| 82249-010 | Abiraterone | tablet | 250 mg/1 | CivicaScript, LLC | None |
| 68001-673 | Abiraterone | tablet | 500 mg/1 | BluePoint Laboratories | None |
| 72205-284 | Abiraterone | tablet, film coated | 250 mg/1 | Novadoz Pharmaceuticals LLC | None |
| 72205-285 | Abiraterone | tablet, film coated | 500 mg/1 | Novadoz Pharmaceuticals LLC | None |
| 82009-140 | Abiraterone | tablet, film coated | 500 mg/1 | Quallent Pharmaceuticals Health LLC | None |
| 0378-6920 | Abiraterone Acetate | tablet | 250 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 0904-6948 | Abiraterone Acetate | tablet | 250 mg/1 | Major Pharmaceuticals | None |
| 16714-963 | Abiraterone Acetate | tablet | 250 mg/1 | NorthStar Rx LLC | None |
| 42291-024 | Abiraterone Acetate | tablet | 250 mg/1 | AvKARE | None |
| 43598-358 | Abiraterone Acetate | tablet | 250 mg/1 | Dr. Reddys Laboratories Inc | None |
| 50268-032 | Abiraterone Acetate | tablet | 250 mg/1 | AvPAK | None |
| 60219-1165 | Abiraterone Acetate | tablet | 250 mg/1 | Amneal Pharmaceuticals LLC | None |
| 60505-4327 | Abiraterone Acetate | tablet | 250 mg/1 | Apotex Corp. | None |
| 60687-790 | Abiraterone Acetate | tablet | 250 mg/1 | American Health Packaging | None |
| 64980-418 | Abiraterone acetate | tablet | 250 mg/1 | Rising Pharma Holdings, Inc. | None |
| 68462-135 | abiraterone acetate | tablet | 250 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69238-1165 | Abiraterone Acetate | tablet | 250 mg/1 | Amneal Pharmaceuticals NY LLC | None |
| 71921-178 | abiraterone acetate | tablet | 250 mg/1 | Florida Pharmaceutical Products, LLC. | None |
| 72603-110 | abiraterone acetate | tablet | 250 mg/1 | NORTHSTAR RX LLC | None |
| 75907-224 | Abiraterone Acetate | tablet | 250 mg/1 | Dr. Reddys Laboratories Inc | None |
| 42291-073 | ABIRATERONE ACETATE | tablet | 500 mg/1 | AvKARE | None |
| 43598-468 | Abiraterone Acetate | tablet | 500 mg/1 | Dr. Reddys Laboratories Inc | None |
| 60219-1754 | ABIRATERONE ACETATE | tablet | 500 mg/1 | Amneal Pharmaceuticals LLC | None |
| 68462-882 | abiraterone acetate | tablet | 500 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69238-1754 | ABIRATERONE ACETATE | tablet | 500 mg/1 | Amneal Pharmaceuticals NY LLC | None |
| 72603-111 | abiraterone acetate | tablet | 500 mg/1 | NORTHSTAR RX LLC | None |
| 82293-001 | Abiraterone Acetate | tablet, film coated | 250 mg/1 | Novugen Pharma (USA) LLC | None |
| 0378-6921 | Abiraterone Acetate | tablet, film coated | 500 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 51407-989 | Abiraterone Acetate | tablet, film coated | 500 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-4764 | abiraterone acetate | tablet, film coated | 500 mg/1 | Apotex Corp. | None |
| 71921-177 | Abiraterone acetate | tablet, film coated | 500 mg/1 | Florida Pharmaceutical Products, LLC | None |
Showing 40 of 43 listings.
Questions
Is abiraterone acetate a controlled substance?
No. Abiraterone acetate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abiraterone acetate is not on the DEA controlled substances list.
Is abiraterone acetate a narcotic?
No. Abiraterone acetate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cytochrome P450 17A1 Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Abiraterone Acetate
- What is Abiraterone Acetate used for?FDA label uses
- Generic for YonsaFDA Orange Book
- Generic for ZytigaFDA Orange Book
- Cytochrome P450 17A1 Inhibitors listFDA drug class
- Abiraterone Acetate Medicare Part D coverageBy plan and state
- NDC 47335-401Abiraterone Acetate NDC record
- NDC 51407-503Abiraterone Acetate NDC record
- NDC 57894-150Abiraterone Acetate NDC record